A Comparison of the Efficacy of Immunomodulatory-containing Regimens in Relapsed/Refractory Multiple Myeloma: A Network Meta-analysis

Meletios A Dimopoulos; Jonathan L. Kaufman; Darrell White; Gordon Cook; Maria Teresa Rizzo; Yingxin Xu; Kyle Fahrbach; Maren Gaudig; Mary Slavcev; Lindsay Dearden; Annette Lam

doi:10.1016/j.clml.2017.12.011

Related publications

Article2017

Efficacy and Safety of Daratumumab-Based Regimens in Patients with Relapsed/Refractory Multiple Myeloma – A Systematic Literature Review and Network Meta-analysis

Meletios A Dimopoulos, Katja Weisel, Jonathan L. Kaufman, Pieter Sonneveld, Maria Teresa Rizzo, Yingxin Xu, Kyle Fahrbach, Maren Gaudig, Mary Slavcev, Annette Lam

Article2022

Pomalidomide- and dexamethasone-based regimens in the treatment of refractory/relapsed multiple myeloma

Despina Fotiou, Maria Gavriatopoulou, Evangelos Terpos, Meletios A Dimopoulos

Article2020

Efficacy and safety of carfilzomib-based regimens in frail patients with relapsed and/or refractory multiple myeloma

Thierry Façon, Rubén Niesvizky, María‐Victoria Mateos, David S. Siegel, Cara A. Rosenbaum, Sara Bringhen, Katja Weisel, P. Joy Ho, Heinz Ludwig, Shaji Kumar, Kenneth T. Wang, Mihaela Obreja, Zhao Yang, Zandra Klippel, Khalid Mezzi, Amanda Goldrick, Christina Tekle, Meletios A Dimopoulos

Article2024

Carfilzomib, daratumumab, and dexamethasone (KdD) vs. lenalidomide-sparing pomalidomide-containing triplet regimens for relapsed/refractory multiple myeloma: an indirect treatment comparison

Katja Weisel, Meletios A Dimopoulos, Meral Beksaç, Xavier Leleu, Joshua Richter, Bart Heeg, Sachin Patel, István Májer, Ian McFadden, Joseph Mıkhael

Article2007

Bone Remodeling in Patients with Relapsed/Refractory Multiple Myeloma Who Receive Lenalidomide-Based Regimens.

Evangelos Terpos, Dimitrios Christoulas, Efstathios Kastritis, Eirini Katodritou, Xenophon Papanikolaou, Μαρία Ρούσσου, Nikolaos A. Stavropoulos, Konstantinos Tsionos, Gerassimos A. Pangalis, Konstantinos Zervas, Orhan Sezer, Meletios A Dimopoulos